Spyre Therapeutics, Inc 10-Q for FY2021 Q3
Spyre Therapeutics, Inc. (SYRE)
10-Q
2021-11-04
For: 2021-09-30
View Original
Added on
April 10, 2026
About this 10-Q
Spyre Therapeutics, Inc filed this 10-Q on November 4, 2021, covering the quarter ended September 30, 2021 (FY2021 Q3).
Headline figures
Quarter ended September 30, 2021, as reported in this filing, compared with the same period a year earlier where the filing states it.
- Revenue
- $1.4M
- Net loss
- $20.31M
- compared with a net loss of $18.03M a year earlier